Adverse Drug Reactions

Large Study Confirms Carotid Stenting Safe, Effective

Published in Biotech Business Week, March 19th, 2007

A multi-center, prospective, single-arm trial of 1,493 patients adds to the growing body of evidence that carotid stenting with embolic protection is safe and effective for patients at the highest risk for adverse events, and substantiates the low adverse event rates reported previously in the SAPPHIRE trial.

The preliminary one-year data from 73 sites, presented today at the Society of Interventional Radiology’s 32nd Annual Scientific Meeting, compares the outcomes of patients in the CASES-PMS trial to those of the SAPPHIRE trial stent cohort, and confirms the long-term results and safety profile of carotid stenting with embolic protection in patients who are high-risk...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2007-03-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry